Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library-Reference-Cited by-同舟云学术

Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library

Published:2017-01-01 Issue:1 Volume:6 Page:1-3
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Niu Hongxia¹²,Ma Chao³,Cui Peng⁴,Shi Wanliang²,Zhang Shuo²,Feng Jie²,Sullivan David²,Zhu Bingdong¹,Zhang Wenhong⁴,Zhang Ying²⁴

Affiliation:

1. Lanzhou Center for Tuberculosis Research and Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China

2. Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA

3. College of Biological Sciences and TechnologyBeijing Forestry University, Beijing 100083, China

4. Key Laboratory of Medical Molecular Virology, Department of Infectious Diseases, Huashan Hospital, Shanghai Medical CollegeFudan University, Shanghai 200040, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/emi201723.pdf

Reference15 articles.

1. World Health Organization. Global tuberculosis report 2016.Geneva: WHO. Available at http://www.who.int/tb/publications/global_report/en/ (accessed 13 October 2016).

2. THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS

3. TB drug discovery: addressing issues of persistence and resistance

4. Targeting Persisters for Tuberculosis Control

5. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses;Bioorganic Chemistry;2023-01

2. The Bewildering Antitubercular Action of Pyrazinamide;Microbiology and Molecular Biology Reviews;2020-05-20

3. The relevance of persisters in tuberculosis drug discovery;Microbiology;2019-05-01

4. Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design;Molecules;2019-01-04

5. Snapshots of catalysis: Structure of covalently bound substrate trapped in Mycobacterium tuberculosis thiazole synthase (ThiG);Biochemical and Biophysical Research Communications;2018-02